| Acute Lymphoblastic Leukemia altered in cohorts of …ALTERED_INderived98 of 98show fewer |
|---|
| ← altered in cohorts of | PRSS1 219 / 768 cases (29 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRSS2 218 / 768 cases (28 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2A 209 / 768 cases (27 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTRNR2L6 209 / 768 cases (27 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2B 183 / 768 cases (24 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTAP 170 / 768 cases (22 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NOTCH1 163 / 768 cases (21 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRTA1 126 / 768 cases (16 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNE 111 / 768 cases (14 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA1 108 / 768 cases (14 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA8 108 / 768 cases (14 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA2 106 / 768 cases (14 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA6 106 / 768 cases (14 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA13 105 / 768 cases (14 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA5 103 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL9 103 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA16 99 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA17 99 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA10 98 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA14 98 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA7 98 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KRAS 97 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA4 96 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA21 95 / 768 cases (12 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNW1 93 / 768 cases (12 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNB1 90 / 768 cases (12 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HACD4 86 / 768 cases (11 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRAS 85 / 768 cases (11 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ELAVL2 77 / 768 cases (10 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOCAD 76 / 768 cases (9.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PAX5 74 / 768 cases (9.6 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXW7 71 / 768 cases (9.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IZUMO3 69 / 768 cases (9.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | JAK2 66 / 768 cases (8.6 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MLLT3 63 / 768 cases (8.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TUSC1 62 / 768 cases (8.1 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EQTN 60 / 768 cases (7.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4Q3 59 / 768 cases (7.7 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MDN1 58 / 768 cases (7.6 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4M1 58 / 768 cases (7.6 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEG 58 / 768 cases (7.6 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TEK 58 / 768 cases (7.6 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR11H12 57 / 768 cases (7.4 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR11H2 57 / 768 cases (7.4 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4N2 57 / 768 cases (7.4 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLAA 57 / 768 cases (7.4 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEM 57 / 768 cases (7.4 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTEN 57 / 768 cases (7.4 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C9orf72 56 / 768 cases (7.3 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CAAP1 56 / 768 cases (7.3 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFT74 56 / 768 cases (7.3 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC19 56 / 768 cases (7.3 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4K2 56 / 768 cases (7.3 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4K5 56 / 768 cases (7.3 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF292 56 / 768 cases (7.3 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BACH2 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CASP8AP2 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPHA7 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GABRR2 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRIK2 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNK 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LINGO2 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MOB3B 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4K1 55 / 768 cases (7.2 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD6 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CFAP206 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CGA 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOP1A 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GABRR1 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GJA10 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LYRM2 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP3K7 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRAGD 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNAP91 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNX14 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBE2J1 54 / 768 cases (7.0 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNR1 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRHPR 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MPDZ 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MRAP2 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PM20D2 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNRC1 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRSS35 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNGTT 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SRSF12 53 / 768 cases (6.9 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYB5R4 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FUT9 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR1E 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL32 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MANEA 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ORC3 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PGM3 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIPPLY2 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RWDD2A 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SIM1 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35A1 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBX18 52 / 768 cases (6.8 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |